medicinal substances
http://www.yso.fi/onto/yso/p1707
Related publications and other outputs
1 of 3
- Simultaneous Determination of Selected Antidiabetic Pharmaceutical Drugs as Adulterants in Herbal Medicines Sold in Kenya Using Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS) (2023) Maina, C.; et al.; A1
- Kinetics of Rifampicin Antibiotic Degradation Using Green Synthesized Iron Oxide Nanoparticles (2022) Wanakai, Indire Sammy; et al.; A1
- New Bioprecursor Prodrugs of Sulfadiazine : Synthesis, X-ray Structure and Hirshfeld Analysis (2022) Altowyan, Mezna Saleh; et al.; A1; OA
- Aggregation versus Biological Activity in Gold(I) Complexes : An Unexplored Concept (2021) Pinto, Andrea; et al.; A1
- Computational cytochrome P450 mediated metabolism and virtual screening (2021) Ahinko, Mira; G5; OA; 978-951-39-8496-0
- Functional DNA nanostructures for molecular transportation and biosensing (2021) Ijäs, Heini; G5; OA; 978-951-39-8556-1
- Ibuprofen degradation using a Co-doped carbon matrix derived from peat as a peroxymonosulphate activator (2021) Ren, Zhongfei; et al.; A1; OA
- Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes : In Vitro Enzyme Kinetics and In Silico Modeling (2021) Juvonen, Risto O.; et al.; A1; OA
- Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release (2021) Ijäs, Heini; et al.; A1; OA
- Contamination of Surface Water and River Sediments by Antibiotic and Antiretroviral Drug Cocktails in Low and Middle-Income Countries : Occurrence, Risk and Mitigation Strategies (2020) Kairigo, Pius; et al.; A1; OA
